Jerome Rifino is the founder and managing partner of Logica Healthcare Group LLC. Jerome has worked to bring advanced testing and wellness solutions to underserved communities, the Veterans Administration, Indian Health Services and other at-risk communities for chronic health issue testing, monitoring and treatment.
Jerome is also founder of Jeromatherapy Limited LLC, a lifestyle improvement and wellness company. Visit Jerome at www.jeromatherapy.com
Maurice has been a partner in Logica Healthcare since 2009. A retired US Army Major, Maurice has extensive experience in contracting and Veterans affairs. Maurice also directs logistics and support for Logica Healthcare and is part of the facilities acquisition and maintenance team.
Aron has recently become a partner in Logica Healthcare ad serves as an advisor on viral testing technology and worldwide distribution. Aron is also CEO of Senzo, a testing kit technology development company based in San Diego, California.
Liz Rifino is a co-founder of Logica Healthcare and is the Director of Global Marketing. Liz has an impressive international presence and is familiar with the challenges of branding and business management in a global marketplace.
Ignyte Healthcare Strategies provides exclusive products and services at wholesale and volume pricing to Healthcare, Medical and Equipment Suppliers, Healthcare Systems, TPAs, Employers, PEOs, Benefit Brokers and Affinity Groups. Ignyte provides products and services to over one million lives and growing.
GG Advisors, LLC has teamed with leading US and European Developers/Manufacturers for immediate shipment, FDA 510K Certified Medical Grade Nitrile Gloves, Gowns, Hand Sanitizer, Covid-19 Resistant and Safety Certified Protective Masks, Rapid Point-of-care or Whole Blood and other critical path back to work/back to school Covid-19 Defense Products.
PhysioPS is a leader in testing and monitoring of the human autonomic nervous system. PhysioPS technology is able to detect autonomic dysfunction and autonomic neuropathy underlying illness that isn’t as easily detected by existing medical diagnostic technology on the market today.